argenx
The Florida & Puerto Rico Market Head leads the strategic direction and performance of local market teams across Alabama, Florida, Georgia, Puerto Rico, and the US Virgin Islands. This role focuses on multi-therapeutic area integration, business planning, and cross-functional leadership to maximize revenue growth and patient impact. The position requires a seasoned business leader with extensive experience in rare disease products and a deep understanding of the US healthcare landscape.
Headquarters
Boston, Massachusetts, United States
Company Size
1001-5000 employees
Founded
2008
Reaching Patients Through Immunology Innovation
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for argenx.
48% above the average for this role
OMG—argenx scores again with Vyvgart in ocular myasthenia gravis
2 weeks ago
Regional Business Manager - South Florida, Puerto Rico
Intellia Therapeutics
Chapter Coordinator - Puerto Rico, Guam and Virgin Islands
National Association of Social Workers
Medical Science Liaison, NMOSD & gMG-Rare Disease - South Florida and Puerto Rico
Amgen
Therapeutic Sales Specialist (Puerto Rico)
BridgeBio Pharma
Corporate Lawyer — Puerto Rico
nearshorebusinesssolutions
Medical Science Liaison / Florida Region
UCB